Evidence map›Paper›PMID 32874065›Full record

ArticleWorld journal of gastroenterology2020

Comment on pediatric living donor liver transplantation decade progress in Shanghai: Characteristics and risks factors of mortality.

Sami Akbulut, Tevfik Tolga Sahin, Sezai Yilmaz

Open access · hybridAbstract readEditorial
In one paragraph

Article in World journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sami AkbulutDeaprtment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya 44280, Turkey. akbulutsami@gmail.com.
Tevfik Tolga SahinDeaprtment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya 44280, Turkey.
Sezai YilmazDeaprtment of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya 44280, Turkey.
Inonu University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the first successful liver transplantation was performed five decades ago, pediatric liver transplantation has become the gold standard treatment choice for pediatric liver disease, including metabolic diseases, liver tumors, and some acute liver failure. With improvements in immunosuppression, surgical techniques, and postoperative medical care, long-term outcomes of patients after liver transplantation have markedly improved, especially in pediatric patients.

Indexed as

Liver TransplantationChildChinaGraft SurvivalHumansImmunosuppression TherapyLiving DonorsPatient SelectionTreatment OutcomeLiving donor liver transplantationLiving donor pediatric liver transplantationOutcomesPediatric end stage liver diseaseRisk factorsSurvival analysis

Identifiers

PMID32874065
PMCPMC7438188
OpenAlexW3049117449

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.